Brad Fluegel is senior vice president - chief strategy and business development officer for Walgreen Co., based in Deerfield, Ill. Fluegel is responsible for corporate strategy and business development, as well as developing and implementing Healthcare Clinic, clinical office and healthcare innovation strategies.
Fluegel joined Walgreens in October 2012 after previously serving as executive in residence at Health Evolution Partners. Before that he was executive vice president and chief strategy and external affairs officer of Wellpoint, among the nation’s largest health benefits companies. While at Wellpoint, Fluegel was responsible for long-term strategic planning, government affairs, corporate communications including public relations, corporate marketing, corporate development, international expansion, innovation and new business ventures.
Prior to Wellpoint, Fluegel was senior vice president of national accounts and vice president, enterprise strategy at Aetna, Inc. In this role, he led the national accounts business and was responsible for developing and executing on strategies that expanded Aetna’s position as a leader in the large employer market. As head of enterprise strategy, Fluegel worked closely with Aetna’s executive committee and board of directors to advance the company’s medium- and long-term business strategies, and ran an internal consulting group responsible for driving management process and operating efficiency across the enterprise.
Earlier, Fluegel was CEO for Reden & Anders (Ingenix Consulting) and Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice that served all sectors of the health care industry. While there, he negotiated the sale of Tillinghast Health to Ingenix. Fluegel also held several roles in strategy, planning and product development and management at Harvard Community Health Plan and organized and led audits, feasibility studies and related projects for health care clients at Arthur Andersen & Co.
In addition to his duties at Walgreens, Fluegel currently serves on the board of directors of Metropolitan Jewish Health System (New York, NY), Health Integrated, Inc. (Tampa, FL) and Performant Financial Corporation (Livermore, CA).
Fluegel earned a master’s degree in public policy from Harvard University’s Kennedy School of Government and a bachelor of arts in business administration from the University of Washington. He also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.